Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study

BACKGROUND: Major depressive disorder (MDD) is a common psychiatric disorder. With systematic antidepressant treatment, 50–75% of patients have a treatment response but require 4–6 weeks to have their symptoms alleviated. Therefore, researchers anticipate the development of novel fast-acting antidep...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yiyi, Cao, Xiaomin, Zang, Wensi, Tan, Shanyong, Ou, Chun-quan, Shen, Xiaoyan, Gao, Tianming, Zhao, Lianxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327443/
https://www.ncbi.nlm.nih.gov/pubmed/30626424
http://dx.doi.org/10.1186/s13063-018-3115-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327443/
https://www.ncbi.nlm.nih.gov/pubmed/30626424
http://dx.doi.org/10.1186/s13063-018-3115-4

Ejemplares similares